CSL Limited: Heart Failure trials
The registry lists 10 Heart Failure studies with CSL Limited as lead sponsor. 0 are open to participants now and 4 have results posted.
Phase 2 2Phase 3 4Phase 4 2No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)CompletedNCT03888066Phase 3Results posted
- Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron DeficiencyCompletedNCT02937454Phase 4Results posted
- Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney DiseaseCompletedNCT01130597Phase 2Results posted
- Evaluation of Patiromer in Heart Failure PatientsCompletedNCT00868439Phase 2Results posted
- Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of HyperkalaemiaCompletedNCT04864795
- Study of the Prevalence of Iron Deficiency in Patients With Heart FailureStatus unknownNCT03924258Not applicable
- A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron DeficiencyCompletedNCT01453608Phase 4
- Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart FailureCompletedNCT01394562Phase 3
- EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart FailureTerminatedNCT00821717Phase 3
- Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)CompletedNCT00520780Phase 3